Table 3.
Average AChE activity with PMP PET
| Region | Mean ± sd |
P |
||||||
|---|---|---|---|---|---|---|---|---|
| All subjects PMP | ET PMP | EPT PMP | No-HT PMP | EPT vs. no-HTa | ET vs. no-HTa | ET vs. EPTb | ANOVAc | |
| n | 50 | 13 | 21 | 16 | ||||
| Left hippocampus | 0.047 ± 0.005 | 0.046 ± 0.006 | 0.049 ± 0.004 | 0.045 ± 0.005 | 0.048 | 0.954 | 0.121 | 0.036 |
| Right hippocampus | 0.043 ± 0.005 | 0.041 ± 0.006 | 0.045 ± 0.005 | 0.041 ± 0.005 | 0.073 | 1.000 | 0.123 | 0.041 |
| Posterior cingulate | 0.028 ± 0.002 | 0.027 ± 0.003 | 0.029 ± 0.002 | 0.027 ± 0.003 | 0.045 | 0.974 | 0.024 | 0.031 |
| Reference region | 0.034 ± 0.003 | 0.033 ± 0.005 | 0.035 ± 0.003 | 0.034 ± 0.002 | 0.430 | 0.872 | 0.086 | 0.205 |
PMP measure is k3 (min−1).
Tukey honestly significant difference post hoc test.
ANCOVA controlling for years on HT.
ANOVA comparison between all three treatment groups.